No Data
Edgewise Therapeutics | 10-Q: Quarterly report
Edgewise Therapeutics Cash, Cash Equivalents and Marketable Securities Were $492.5M as of Sept 30 >EWTX
Press Release: Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Express News | Edgewise Therapeutics Q3 Net Income USD -34.129 Million
Express News | Edgewise Therapeutics Q3 Basic EPS USD -0.36
Earnings Preview: EWTX to Report Financial Results Pre-market on November 07
$Edgewise Therapeutics(EWTX.US)$ is scheduled to release its financial results pre-market on November 07 ET. Earnings PreviewAnalysts estimate $Edgewise Therapeutics(EWTX.US)$ to post revenue of USD0